Latest News and Press Releases

Dublin, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The "How to Deal with Difficult Situations in GMP (Good Manufacturing Practice) Audits Training Course (Mar 5, 2026)" training has been added to ...

Dublin, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The "How to Interview During GMP (Good Manufacturing Practice) Audits Training Course (Mar 12, 2026)" training has been added to ResearchAndMarkets.com's...

Austin, TX, USA, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cell Therapy Raw Materials Market Size, Trends and Insights By Product (Media,...

Dublin, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The "Oligonucleotide CDMO Market Size, Share & Trends Analysis Report by Service (Contract Development, Contract Manufacturing), Type (Antisense...

Dublin, Jan. 16, 2026 (GLOBE NEWSWIRE) -- The "GMP Auditing for Quality Assurance Training Course for FDA Regulated Industries (Jan 28th - Jan 29th, 2026)" training has been added to ...

Dublin, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The "New EU (European Union) GMP (Good Manufacturing Practice) Annex 1: Compliant Aseptic Operations Training Course (May 19th - May 21st, 2026)" training...

Dublin, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The "FDA's 21 CFR Part 11 Add-on Inspections (Jan 12, 2026)" training has been added to ResearchAndMarkets.com's offering.The verification and validation...

NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine...

3CHI earned a 98% CSQ cGMP audit score with operations audited against food & dietary supplement frameworks (21 CFR 111/117) at its 112,000 sq-ft facility

First publicly listed company to actively investigate psilocybin’s potential impact on longevity NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed”...